These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 11938417

  • 1. Efficacy of erythropoietin in premature infants.
    Amin AA, Alzahrani DM.
    Saudi Med J; 2002 Mar; 23(3):287-90. PubMed ID: 11938417
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recombinant human erythropoietin and blood transfusion in low-birth weight preterm infants under restrictive transfusion guidelines.
    Badiee Z, Pourmirzaiee MA, Kelishadi R, Naseri F.
    Saudi Med J; 2006 Jun; 27(6):817-20. PubMed ID: 16758042
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants.
    Haiden N, Schwindt J, Cardona F, Berger A, Klebermass K, Wald M, Kohlhauser-Vollmuth C, Jilma B, Pollak A.
    Pediatrics; 2006 Nov; 118(5):2004-13. PubMed ID: 17079573
    [Abstract] [Full Text] [Related]

  • 11. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g.
    Maier RF, Obladen M, Müller-Hansen I, Kattner E, Merz U, Arlettaz R, Groneck P, Hammer H, Kössel H, Verellen G, Stock GJ, Lacaze-Masmonteil T, Claris O, Wagner M, Matis J, Gilberg F, European Multicenter Erythropoietin Beta Study Group.
    J Pediatr; 2002 Jul; 141(1):8-15. PubMed ID: 12091844
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants.
    Türker G, Sarper N, Gökalp AS, Usluer H.
    Am J Perinatol; 2005 Nov; 22(8):449-55. PubMed ID: 16283605
    [Abstract] [Full Text] [Related]

  • 16. [Criteria for diagnosis and therapy of hyporegeneratory anemia in premature newborns below 33 week of gestation and body weight below 1500 grams].
    Pramatarova T, Vakrilova L, Slŭncheva B, Iarŭkova N, Kalaĭdzhieva M, Emilova Z, Shishkova R, Popivanova A, Zhekova N.
    Akush Ginekol (Sofiia); 2007 Nov; 46 Suppl 1():63-6. PubMed ID: 18173017
    [Abstract] [Full Text] [Related]

  • 17. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.
    Ohls RK, Ehrenkranz RA, Das A, Dusick AM, Yolton K, Romano E, Delaney-Black V, Papile LA, Simon NP, Steichen JJ, Lee KG, National Institute of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Optimizing the approach to anemia in the preterm infant: is there a role for erythropoietin therapy?
    Asch J, Wedgwood JF.
    J Perinatol; 1997 Nov; 17(4):276-82. PubMed ID: 9280091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.